ArticleAnnals of hematology2020

Could ruxolitinib be effective in patients with COVID-19 infection at risk of acute respiratory distress syndrome (ARDS)?

Giovanni Caocci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.